Multiphasic and Dynamic Changes in Alternative Splicing during Induction of Pluripotency Are Coordinated by Numerous RNA-Binding Proteins

Cell Reports

Volumn 15, Issue 2, 2016, Pages 247-255

  Cieply, Benjamin ^a   Park, Juw Won ^b,e,f   Nakauka Ddamba, Angela ^c   Bebee, Thomas W ^a   Guo, Yang ^b,d   Shang, Xuequn ^d   Lengner, Christopher J ^c   Xing, Yi ^b   Carstens, Russ P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d NORTHWESTERN POLYTECHNICAL UNIVERSITY   (China)

^e University of Louisville   (United States)

^f UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN ESRP1; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; ESRP1 PROTEIN, MOUSE; GRHL1 PROTEIN, MOUSE; ISOPROTEIN; REPRESSOR PROTEIN;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; EMBRYO; FIBROBLAST; GENE; GENE CONTROL; GENE EXPRESSION; GENE TARGETING; GRHL1 GENE; MESENCHYMAL EPITHELIAL TRANSITION; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SOMATIC CELL; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; GENOME; INDUCED PLURIPOTENT STEM CELL; METABOLISM; TIME FACTOR;

ALTERNATIVE SPLICING; ANIMALS; CELLULAR REPROGRAMMING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENOME; INDUCED PLURIPOTENT STEM CELLS; MICE; PROTEIN ISOFORMS; REPRESSOR PROTEINS; RNA-BINDING PROTEINS; TIME FACTORS;

EID: 84962045599     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.03.025     Document Type: Article

References (28)

1. Bebee T.W., Park J.W., Sheridan K.I., Warzecha C.C., Cieply B.W., Rohacek A.M., Xing Y., Carstens R.P. The splicing regulators Esrp1 and Esrp2 direct an epithelial splicing program essential for mammalian development. eLife 2015, 4:e08954.
2. Brambrink T., Foreman R., Welstead G.G., Lengner C.J., Wernig M., Suh H., Jaenisch R. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2008, 2:151-159.
3. Chen M., Manley J.L. Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat. Rev. Mol. Cell Biol. 2009, 10:741-754.
4. Cieply B., Carstens R.P. Functional roles of alternative splicing factors in human disease. Wiley Interdiscip. Rev. RNA 2015, 6:311-326.
5. Dittmar K.A., Jiang P., Park J.W., Amirikian K., Wan J., Shen S., Xing Y., Carstens R.P. Genome-wide determination of a broad ESRP-regulated posttranscriptional network by high-throughput sequencing. Mol. Cell. Biol. 2012, 32:1468-1482.
6. Dolfini D., Minuzzo M., Pavesi G., Mantovani R. The short isoform of NF-YA belongs to the embryonic stem cell transcription factor circuitry. Stem Cells 2012, 30:2450-2459.
7. Gabut M., Samavarchi-Tehrani P., Wang X., Slobodeniuc V., O'Hanlon D., Sung H.K., Alvarez M., Talukder S., Pan Q., Mazzoni E.O., et al. An alternative splicing switch regulates embryonic stem cell pluripotency and reprogramming. Cell 2011, 147:132-146.
8. Han H., Irimia M., Ross P.J., Sung H.K., Alipanahi B., David L., Golipour A., Gabut M., Michael I.P., Nachman E.N., et al. MBNL proteins repress ES-cell-specific alternative splicing and reprogramming. Nature 2013, 498:241-245.
9. Jiang S.W., Trujillo M.A., Sakagashira M., Wilke R.A., Eberhardt N.L. Novel human TEF-1 isoforms exhibit altered DNA binding and functional properties. Biochemistry 2000, 39:3505-3513.
10. Kalsotra A., Cooper T.A. Functional consequences of developmentally regulated alternative splicing. Nat. Rev. Genet. 2011, 12:715-729.
11. Lengner C.J. iPS cell technology in regenerative medicine. Ann. N Y Acad. Sci. 2010, 1192:38-44.
12. Li R., Liang J., Ni S., Zhou T., Qing X., Li H., He W., Chen J., Li F., Zhuang Q., et al. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell 2010, 7:51-63.
13. Liang J., Wan M., Zhang Y., Gu P., Xin H., Jung S.Y., Qin J., Wong J., Cooney A.J., Liu D., Songyang Z. Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells. Nat. Cell Biol. 2008, 10:731-739.
14. Ohta S., Nishida E., Yamanaka S., Yamamoto T. Global splicing pattern reversion during somatic cell reprogramming. Cell Rep. 2013, 5:357-366.
15. Roder K., Wolf S.S., Larkin K.J., Schweizer M. Interaction between the two ubiquitously expressed transcription factors NF-Y and Sp1. Gene 1999, 234:61-69.
16. Salomonis N., Schlieve C.R., Pereira L., Wahlquist C., Colas A., Zambon A.C., Vranizan K., Spindler M.J., Pico A.R., Cline M.S., et al. Alternative splicing regulates mouse embryonic stem cell pluripotency and differentiation. Proc. Natl. Acad. Sci. USA 2010, 107:10514-10519.
17. Samavarchi-Tehrani P., Golipour A., David L., Sung H.K., Beyer T.A., Datti A., Woltjen K., Nagy A., Wrana J.L. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell 2010, 7:64-77.
18. Segre J.A., Bauer C., Fuchs E. Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat. Genet. 1999, 22:356-360.
19. Shen S., Park J.W., Lu Z.X., Lin L., Henry M.D., Wu Y.N., Zhou Q., Xing Y. rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data. Proc. Natl. Acad. Sci. USA 2014, 111:E5593-E5601.
20. Stadtfeld M., Maherali N., Borkent M., Hochedlinger K. A reprogrammable mouse strain from gene-targeted embryonic stem cells. Nat. Methods 2010, 7:53-55.
21. Vanharanta S., Marney C.B., Shu W., Valiente M., Zou Y., Mele A., Darnell R.B., Massagué J. Loss of the multifunctional RNA-binding protein RBM47 as a source of selectable metastatic traits in breast cancer. eLife 2014, 3:e02734.
22. Venables J.P., Lapasset L., Gadea G., Fort P., Klinck R., Irimia M., Vignal E., Thibault P., Prinos P., Chabot B., et al. MBNL1 and RBFOX2 cooperate to establish a splicing programme involved in pluripotent stem cell differentiation. Nat. Commun. 2013, 4:2480.
23. Warzecha C.C., Sato T.K., Nabet B., Hogenesch J.B., Carstens R.P. ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing. Mol. Cell 2009, 33:591-601.
24. Warzecha C.C., Jiang P., Amirikian K., Dittmar K.A., Lu H., Shen S., Guo W., Xing Y., Carstens R.P. An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transition. EMBO J. 2010, 29:3286-3300.
25. Wernig M., Meissner A., Foreman R., Brambrink T., Ku M., Hochedlinger K., Bernstein B.E., Jaenisch R. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007, 448:318-324.
26. Wu J.Q., Habegger L., Noisa P., Szekely A., Qiu C., Hutchison S., Raha D., Egholm M., Lin H., Weissman S., et al. Dynamic transcriptomes during neural differentiation of human embryonic stem cells revealed by short, long, and paired-end sequencing. Proc. Natl. Acad. Sci. USA 2010, 107:5254-5259.
27. Yaguchi M., Wada Y., Toh Y., Iguchi H., Kono A., Matsusue K., Takiguchi S. Identification and characterization of the variants of metastasis-associated protein 1 generated following alternative splicing. Biochim. Biophys. Acta 2005, 1732:8-14.
28. Yeo G.W., Coufal N.G., Liang T.Y., Peng G.E., Fu X.D., Gage F.H. An RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein interactions in stem cells. Nat. Struct. Mol. Biol. 2009, 16:130-137.